Entry |
|
Name |
Doxifluridine (JP18/INN); Furtulon (TN) |
Formula |
C9H11FN2O5
|
Exact mass |
246.0652
|
Mol weight |
246.1924
|
Structure |

|
Simcomp |
|
Class |
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01935 Fluoropyrimidine antineoplastic
|
Remark |
Therapeutic category: | 4223 |
|
Efficacy |
Antineoplastic, Antimetabolite |
Comment |
Active form of prodrug: Fluorouracil [DR: D00584]
|
Target |
|
Pathway |
|
Interaction |
|
Structure map |
map07041 | Antineoplastics - antimetabolic agents |
|
Other map |
map00983 | Drug metabolism - other enzymes |
|
Brite |
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
422 Antimetabolites
4223 Fluorouracils
D01309 Doxifluridine (JP18/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01935 Fluoropyrimidine antineoplastic
D01309 Doxifluridine
Drug classes [BR:br08332]
Antineoplastic
DG02018 Antimetabolite
D01309 Doxifluridine
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Methyltransferases
TYMS
D01309 Doxifluridine (JP18/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01309 Doxifluridine
D01309 Doxifluridine capsules
Prodrugs [br08324.html]
D01309
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 17
1 C1y C 22.8703 -17.4990
2 N4y N 24.5207 -16.9314
3 O2x O 21.7034 -16.6238
4 C1y C 22.4328 -18.8118
5 C8y C 25.7785 -17.6293
6 C8x C 24.4865 -15.5558
7 C1y C 20.6094 -17.4261
8 C1y C 21.0470 -18.8118
9 O1a O 23.2350 -19.9058
10 N4x N 26.9723 -16.9258
11 O5x O 25.7354 -18.9679
12 C8y C 25.7504 -14.8522
13 O1a O 20.2448 -19.9058
14 C8y C 26.9711 -15.4873
15 O5x O 28.1650 -14.7838
16 C1a C 19.2967 -17.0614
17 X F 25.7492 -13.4138
BOND 18
1 1 3 1
2 1 4 1
3 2 5 1
4 2 6 1
5 3 7 1
6 4 8 1
7 4 9 1 #Down
8 5 10 1
9 5 11 2
10 6 12 2
11 8 13 1 #Down
12 10 14 1
13 14 15 2
14 7 8 1
15 12 14 1
16 7 16 1 #Up
17 1 2 1 #Up
18 12 17 1
|